March 04, 2025 07:14 am (IST)
Follow us:
facebook-white sharing button
twitter-white sharing button
instagram-white sharing button
youtube-white sharing button
Haryana Congress worker murder: Video emerges showing accused dragging suitcase with Himani Narwal's body inside it | Supreme Court slams 'oversmart' Samay Raina for making fun of proceedings in Canada, asks him to 'behave' | Indian woman facing death row in UAE for killing a child has been executed: Foreign ministry tells court | Crucial to have Trump’s support, says Zelenskyy a day after fiery White House exchange | 'We're looking for peace, Zelenskyy wants Russia-Ukraine war to continue': Donald Trump after White House public spat | Volodymyr Zelenskyy refuses to apologise to Donald Trump after public spat over Russia-Ukraine war | 'Make a deal or we are out': Donald Trump tells Volodymyr Zelenskyy at White House | Himachal govt seeks fund from temple to support welfare schemes, BJP calls move 'shocking' | Injustice to opposition MLAs: Atishi writes to Delhi Assembly Speaker on suspension of 21 AAP lawmakers | We will leave for US tomorrow: Father of Indian student Neelam Shinde after urgent visa grant
India gives nod to two more anti-COVID-19 vaccines, one drug

India gives nod to two more anti-COVID-19 vaccines, one drug

Dec 28, 2021, at 07:04 pm

New Delhi/IBNS: Strengthening the fight against COVID-19, the Union Health Ministry on Tuesday gave nod to two more anti-COVID-19 vaccines and a drug to battle the deadly virus.

WHO grants emergency approval to Serum Insitute's COVID vaccine 'Covovax'

WHO grants emergency approval to Serum Insitute's COVID vaccine 'Covovax'

Dec 18, 2021, at 03:34 am

Geneva/IBNS: The World Health Organization (WHO) on Friday announced that  it has granted emergency approval to the India-manufactured COVID-19 vaccine Covovax.

Novavax may get approval in two months, likely to be costlier than Covishield

Novavax may get approval in two months, likely to be costlier than Covishield

Jul 01, 2021, at 02:28 am

New Delhi/IBNS: The Covovax shot developed by US vaccine-maker Novavax may be cleared for use in India between July and September, which would make it the fifth vaccine approved in the South Asian country.